Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2015; 5(10): 073-079


Degradation of cefdinir from pharmaceutical wastewater using immobilized Candida sp. SMN04 and biofilm formed on gravels

Adikesavan Selvi, Monidipa Banerjee, Nilanjana Das.




Abstract

Cefdinir being a semi-synthetic third generation cephalosporin antibiotic is considered as an emerging pollutant which demands removal from environment. Degradation of cefdinir by yeast Candida sp. SMN04 immobilized on various single and hybrid matrices was investigated using entrapment method. The biofilm forming ability of Candida sp. was evaluated by crystal violet staining assay and the formed biofilm was monitored by SEM and AFM analysis. The amount of exopolysaccharides (EPS) produced by Candida sp. was quantified and characterized by FTIR, HPLC and TGA analysis respectively. Cefdinir degradation from pharmaceutical wastewater was found to be 96.6% and 92.2% by PVA-alginate immobilized yeast and yeast biofilm formed on gravels over a period of 48 h in batch mode. Effectiveness of the process was also tested involving continuous-flow column studies. This is the first successful attempt on cefdinir degradation using immobilized yeast cells and yeast biofilm on solid substrate.

Key words: Biofilm, Cefdinir, Degradation, Immobilization, Pharmaceutical wastewater.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.